Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
91 studies found for:    Open Studies | "Mesothelioma"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Mesothelioma"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Pilot Window-Of-Opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma
Condition: Pleural Mesothelioma
Interventions: Drug: Pembrolizumab;   Drug: Cisplatin and Pemetrexed
2 Recruiting PIT: Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma
Condition: Mesothelioma
Intervention: Radiation: Prophylactic Irradiation of Tracts (PIT)
3 Not yet recruiting Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma
Conditions: Mesothelioma;   Pleural Mesothelioma
Interventions: Drug: Concurrent Durvalumab;   Drug: Maintenance Durvalumab
4 Not yet recruiting Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment
Condition: Mesothelioma
Intervention: Drug: Oshadi D and Oshadi R
5 Recruiting Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Condition: Mesothelioma
Intervention:
6 Recruiting Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma
Condition: Mesothelioma
Interventions: Drug: Cisplatin;   Drug: Pemetrexed;   Drug: Pembrolizumab
7 Recruiting Intrapleural Cryotherapy for Malignant Pleural Mesothelioma
Condition: Mesothelioma
Interventions: Device: Cryotherapy;   Other: Control
8 Not yet recruiting Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma
Intervention: Other: CD 74, VEGF detection
9 Recruiting ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM)
Condition: Malignant Pleural Mesothelioma
Intervention: Drug: Trabectedin
10 Recruiting Dendritic Cells Loaded With Allogeneous Cell Lysate in Mesothelioma Patients
Condition: Mesothelioma
Intervention: Biological: MesoCancerVac
11 Recruiting MEDI4736 Or MEDI4736 + Tremelimumab In Surgically Resectable Malignant Pleural Mesothelioma
Condition: Mesothelioma
Interventions: Drug: MEDI4736;   Drug: Tremelimumab;   Other: Untreated arm (control)
12 Recruiting Nintedanib (BIBF 1120) in Mesothelioma
Condition: Mesothelioma
Interventions: Drug: Nintedanib;   Drug: Pemetrexed;   Drug: Cisplatin;   Drug: Placebo
13 Recruiting Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)
Condition: Mesothelioma
Interventions: Drug: Anetumab ravtansine (BAY 94-9343);   Drug: Vinorelbine
14 Recruiting Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients
Condition: Mesothelioma
Interventions: Biological: Nivolumab;   Biological: Ipilimumab;   Drug: Pemetrexed;   Drug: Cisplatin;   Drug: Carboplatin
15 Recruiting Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma
Condition: Mesothelioma
Interventions: Procedure: Pleurectomy/Decortication;   Drug: pemetrexed and cisplatin or carboplatin;   Radiation: Intensity Modulated Radiation Therapy
16 Recruiting Window of Opportunity Study of VS-6063 (Defactinib) in Participants With Surgical Resectable Malignant Pleural Mesothelioma.
Condition: Malignant Pleural Mesothelioma
Intervention: Drug: VS-6063
17 Recruiting Intrapleural Photodynamic Therapy in a Multimodal Treatment for Patients With Malignant Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma
Interventions: Device: photodynamic therapy (PDT);   Procedure: thoracic surgery Pleurectomy / extended Decortication;   Drug: Adjuvant chemotherapy
18 Recruiting MARS 2: A Feasibility Study Comparing (Extended) Pleurectomy Decortication Versus no Pleurectomy Decortication in Patients With Malignant Pleural Mesothelioma
Condition: Mesothelioma
Intervention: Procedure: (Extended) pleurectomy decortication
19 Recruiting 11C-Methionine PET/CT Imaging in Patients Affected by Malignant Pleural Mesothelioma (MPM)
Condition: Mesothelioma, Malignant
Intervention: Other: No intervention
20 Recruiting A Phase Ib Trial of a Maintenance Multipeptide Vaccine (S-588210) in Patients With Unresectable Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy
Condition: Malignant Pleural Mesothelioma (MPM)
Intervention: Biological: Multipeptide vaccine S-588210

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.